Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1988 Sep;82(3):950–957. doi: 10.1172/JCI113703

Structural and functional characterization of the human T lymphocyte receptor for insulin-like growth factor I in vitro.

V F Tapson 1, M Boni-Schnetzler 1, P F Pilch 1, D M Center 1, J S Berman 1
PMCID: PMC303607  PMID: 3262126

Abstract

Growth factor receptors for T lymphocytes, such as interleukin 2 and insulin, are present on activated but not resting T lymphocytes. We sought to determine if insulin-like growth factor I (IGF-I) could act as a growth factor for human T cells and to characterize its receptor on resting and activated cells. Recombinant IGF-I induced two separate functions. It was chemotactic for and increased incorporation of tritiated thymidine into both unactivated (resting) and mitogen-activated T cells. High-affinity 125I-IGF-I binding to human T cells was saturable with an apparent Kd of 1.2 +/- .6 X 10(-10) M for binding to activated T cells and 1.2 +/- .9 X 10(-10) for unactivated T cells. The calculated binding for activated cells was 330 +/- 90 and for resting cells 45 +/- 9 high-affinity receptor sites per cell. Affinity cross-linking of 125I-IGF-I to resting or activated T cells revealed a radioligand-receptor complex of 360,000 mol wt when analyzed by SDS-PAGE without reduction and complexes of 270,000 and 135,000 mol wt upon reduction; prior incubation with excess unlabeled IGF-I prevented formation of the 125I-IGF-I receptor complex. Our data suggest that both resting and activated T lymphocytes bear functional IGF-I receptors similar to those found in other tissues. These receptors may mediate T cell growth and chemotaxis.

Full text

PDF
950

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOYDEN S. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med. 1962 Mar 1;115:453–466. doi: 10.1084/jem.115.3.453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baxter R. C., Williams P. F. Reciprocal modulation of insulin and insulin-like growth factor-I receptor affinity by calcium. Biochem Biophys Res Commun. 1983 Oct 14;116(1):62–67. doi: 10.1016/0006-291x(83)90380-7. [DOI] [PubMed] [Google Scholar]
  3. Beguinot F., Kahn C. R., Moses A. C., Smith R. J. Distinct biologically active receptors for insulin, insulin-like growth factor I, and insulin-like growth factor II in cultured skeletal muscle cells. J Biol Chem. 1985 Dec 15;260(29):15892–15898. [PubMed] [Google Scholar]
  4. Berman J. S., Center D. M. Chemotactic activity of porcine insulin for human T lymphocytes in vitro. J Immunol. 1987 Apr 1;138(7):2100–2103. [PubMed] [Google Scholar]
  5. Burgess S. K., Jacobs S., Cuatrecasas P., Sahyoun N. Characterization of a neuronal subtype of insulin-like growth factor I receptor. J Biol Chem. 1987 Feb 5;262(4):1618–1622. [PubMed] [Google Scholar]
  6. Chernausek S. D., Jacobs S., Van Wyk J. J. Structural similarities between human receptors for somatomedin C and insulin: analysis by affinity labeling. Biochemistry. 1981 Dec 22;20(26):7345–7350. doi: 10.1021/bi00529a004. [DOI] [PubMed] [Google Scholar]
  7. Clemmons D. R., Shaw D. S. Purification and biologic properties of fibroblast somatomedin. J Biol Chem. 1986 Aug 5;261(22):10293–10298. [PubMed] [Google Scholar]
  8. Clemmons D. R., Shaw D. S. Variables controlling somatomedin production by cultured human fibroblasts. J Cell Physiol. 1983 May;115(2):137–142. doi: 10.1002/jcp.1041150206. [DOI] [PubMed] [Google Scholar]
  9. Clemmons D. R., Underwood L. E., Van Wyk J. J. Hormonal control of immunoreactive somatomedin production by cultured human fibroblasts. J Clin Invest. 1981 Jan;67(1):10–19. doi: 10.1172/JCI110001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Clemmons D. R., Van Wyk J. J. Evidence for a functional role of endogenously produced somatomedinlike peptides in the regulation of DNA synthesis in cultured human fibroblasts and porcine smooth muscle cells. J Clin Invest. 1985 Jun;75(6):1914–1918. doi: 10.1172/JCI111906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Davies G. E., Stark G. R. Use of dimethyl suberimidate, a cross-linking reagent, in studying the subunit structure of oligomeric proteins. Proc Natl Acad Sci U S A. 1970 Jul;66(3):651–656. doi: 10.1073/pnas.66.3.651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. De Meyts P., Roth J. Cooperativity in ligand binding: a new graphic analysis. Biochem Biophys Res Commun. 1975 Oct 27;66(4):1118–1126. doi: 10.1016/0006-291x(75)90473-8. [DOI] [PubMed] [Google Scholar]
  13. Deuel T. F., Senior R. M., Huang J. S., Griffin G. L. Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. J Clin Invest. 1982 Apr;69(4):1046–1049. doi: 10.1172/JCI110509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Froesch E. R., Schmid C., Schwander J., Zapf J. Actions of insulin-like growth factors. Annu Rev Physiol. 1985;47:443–467. doi: 10.1146/annurev.ph.47.030185.002303. [DOI] [PubMed] [Google Scholar]
  15. Gootenberg J. E., Ruscetti F. W., Mier J. W., Gazdar A., Gallo R. C. Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factor. J Exp Med. 1981 Nov 1;154(5):1403–1418. doi: 10.1084/jem.154.5.1403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Guler H. P., Zapf J., Froesch E. R. Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N Engl J Med. 1987 Jul 16;317(3):137–140. doi: 10.1056/NEJM198707163170303. [DOI] [PubMed] [Google Scholar]
  17. Han V. K., D'Ercole A. J., Lund P. K. Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus. Science. 1987 Apr 10;236(4798):193–197. doi: 10.1126/science.3563497. [DOI] [PubMed] [Google Scholar]
  18. Helderman J. H., Reynolds T. C., Strom T. B. The insulin receptor as a universal marker of activated lymphocytes. Eur J Immunol. 1978 Aug;8(8):589–595. doi: 10.1002/eji.1830080810. [DOI] [PubMed] [Google Scholar]
  19. Helderman J. H., Strom T. B. Emergence of insulin receptors upon alloimmune T cells in the rat. J Clin Invest. 1977 Feb;59(2):338–344. doi: 10.1172/JCI108646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Helderman J. H., Strom T. B. Specific insulin binding site on T and B lymphocytes as a marker of cell activation. Nature. 1978 Jul 6;274(5666):62–63. doi: 10.1038/274062a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Herzberg V. L., Smith K. A. T cell growth without serum. J Immunol. 1987 Aug 15;139(4):998–1004. [PubMed] [Google Scholar]
  22. Hunninghake G. W., Glazier A. J., Monick M. M., Dinarello C. A. Interleukin-1 is a chemotactic factor for human T-lymphocytes. Am Rev Respir Dis. 1987 Jan;135(1):66–71. doi: 10.1164/arrd.1987.135.1.66. [DOI] [PubMed] [Google Scholar]
  23. Hunt P., Eardley D. D. Suppressive effects of insulin and insulin-like growth factor-1 (IGF1) on immune responses. J Immunol. 1986 Jun 1;136(11):3994–3999. [PubMed] [Google Scholar]
  24. Isley W. L., Underwood L. E., Clemmons D. R. Dietary components that regulate serum somatomedin-C concentrations in humans. J Clin Invest. 1983 Feb;71(2):175–182. doi: 10.1172/JCI110757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Izumi T., Kasuga M., Kadowaki T., Hizuka N., Takaku F., Akanuma Y. Characteristics of human erythrocyte insulin-like growth factor I receptors. J Clin Endocrinol Metab. 1986 Jun;62(6):1206–1212. doi: 10.1210/jcem-62-6-1206. [DOI] [PubMed] [Google Scholar]
  26. Julius M. H., Simpson E., Herzenberg L. A. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol. 1973 Oct;3(10):645–649. doi: 10.1002/eji.1830031011. [DOI] [PubMed] [Google Scholar]
  27. Kadowaki T., Koyasu S., Nishida E., Sakai H., Takaku F., Yahara I., Kasuga M. Insulin-like growth factors, insulin, and epidermal growth factor cause rapid cytoskeletal reorganization in KB cells. Clarification of the roles of type I insulin-like growth factor receptors and insulin receptors. J Biol Chem. 1986 Dec 5;261(34):16141–16147. [PubMed] [Google Scholar]
  28. Kasuga M., Van Obberghen E., Nissley S. P., Rechler M. M. Demonstration of two subtypes of insulin-like growth factor receptors by affinity cross-linking. J Biol Chem. 1981 Jun 10;256(11):5305–5308. [PubMed] [Google Scholar]
  29. Kasuga M., Van Obberghen E., Nissley S. P., Rechler M. M. Structure of the insulin-like growth factor receptor in chicken embryo fibroblasts. Proc Natl Acad Sci U S A. 1982 Mar;79(6):1864–1868. doi: 10.1073/pnas.79.6.1864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. King G. L., Kahn C. R., Rechler M. M., Nissley S. P. Direct demonstration of separate receptors for growth and metabolic activities of insulin and multiplication-stimulating activity (an insulinlike growth factor) using antibodies to the insulin receptor. J Clin Invest. 1980 Jul;66(1):130–140. doi: 10.1172/JCI109826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Kornfeld H., Berman J. S., Beer D. J., Center D. M. Induction of human T lymphocyte motility by interleukin 2. J Immunol. 1985 Jun;134(6):3887–3890. [PubMed] [Google Scholar]
  32. Krug U., Krug F., Cuatrecasas P. Emergence of insulin receptors on human lymphocytes during in vitro transformation. Proc Natl Acad Sci U S A. 1972 Sep;69(9):2604–2608. doi: 10.1073/pnas.69.9.2604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Laron Z. Laron-type dwarfism (hereditary somatomedin deficiency): a review. Ergeb Inn Med Kinderheilkd. 1984;51:117–150. doi: 10.1007/978-3-642-69070-9_3. [DOI] [PubMed] [Google Scholar]
  34. Lin T., Haskell J., Vinson N., Terracio L. Characterization of insulin and insulin-like growth factor I receptors of purified Leydig cells and their role in steroidogenesis in primary culture: a comparative study. Endocrinology. 1986 Oct;119(4):1641–1647. doi: 10.1210/endo-119-4-1641. [DOI] [PubMed] [Google Scholar]
  35. Marshall R. N., Underwood L. E., Voina S. J., Foushee D. B., Van Wyk J. J. Characterization of the insulin and somatomedin-C receptors in human placental cell membranes. J Clin Endocrinol Metab. 1974 Aug;39(2):283–292. doi: 10.1210/jcem-39-2-283. [DOI] [PubMed] [Google Scholar]
  36. Massagué J., Czech M. P. The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor. J Biol Chem. 1982 May 10;257(9):5038–5045. [PubMed] [Google Scholar]
  37. Merimee T. J., Zapf J., Hewlett B., Cavalli-Sforza L. L. Insulin-like growth factors in pygmies. The role of puberty in determining final stature. N Engl J Med. 1987 Apr 9;316(15):906–911. doi: 10.1056/NEJM198704093161503. [DOI] [PubMed] [Google Scholar]
  38. Miossec P., Yu C. L., Ziff M. Lymphocyte chemotactic activity of human interleukin 1. J Immunol. 1984 Oct;133(4):2007–2011. [PubMed] [Google Scholar]
  39. Morgan D. O., Jarnagin K., Roth R. A. Purification and characterization of the receptor for insulin-like growth factor I. Biochemistry. 1986 Sep 23;25(19):5560–5564. doi: 10.1021/bi00367a032. [DOI] [PubMed] [Google Scholar]
  40. Peters K., Richards F. M. Chemical cross-linking: reagents and problems in studies of membrane structure. Annu Rev Biochem. 1977;46:523–551. doi: 10.1146/annurev.bi.46.070177.002515. [DOI] [PubMed] [Google Scholar]
  41. Pilch P. F., Czech M. P. Interaction of cross-linking agents with the insulin effector system of isolated fat cells. Covalent linkage of 125I-insulin to a plasma membrane receptor protein of 140,000 daltons. J Biol Chem. 1979 May 10;254(9):3375–3381. [PubMed] [Google Scholar]
  42. Pilch P. F., Czech M. P. The subunit structure of the high affinity insulin receptor. Evidence for a disulfide-linked receptor complex in fat cell and liver plasma membranes. J Biol Chem. 1980 Feb 25;255(4):1722–1731. [PubMed] [Google Scholar]
  43. Pilch P. F., O'Hare T., Rubin J., Boni-Schnetzler M. The ligand binding subunit of the insulin-like growth factor 1 receptor has properties of a peripheral membrane protein. Biochem Biophys Res Commun. 1986 Apr 14;136(1):45–50. doi: 10.1016/0006-291x(86)90874-0. [DOI] [PubMed] [Google Scholar]
  44. Rechler M. M., Eisen H. J., Higa O. Z., Nissley P., Moses A. C., Schilling E. E., Fennoy I., Bruni C. B., Phillips L. S., Baird K. L. Characterization of a somatomedin (insulin-like growth factor) synthesized by fetal rat liver organ cultures. J Biol Chem. 1979 Aug 25;254(16):7942–7950. [PubMed] [Google Scholar]
  45. Rechler M. M., Nissley S. P., Podskalny J. M., Moses A. C., Fryklund L. Identification of a receptor for somatomedin-like polypeptides in human fibroblasts. J Clin Endocrinol Metab. 1977 May;44(5):820–831. doi: 10.1210/jcem-44-5-820. [DOI] [PubMed] [Google Scholar]
  46. Rosenfeld R. G., Dollar L. A. Characterization of the somatomedin-C/insulin-like growth factor I (SM-C/IGF-I) receptor on cultured human fibroblast monolayers: regulation of receptor concentrations by SM-C/IGF-I and insulin. J Clin Endocrinol Metab. 1982 Sep;55(3):434–440. doi: 10.1210/jcem-55-3-434. [DOI] [PubMed] [Google Scholar]
  47. Rosenfeld R. G., Dollar L. A., Conover C. A. Density-associated loss of functional receptors for somatomedin-C/insulinlike growth factor I (SM-C/IGF-I) on cultured human fibroblast monolayers. J Cell Physiol. 1984 Nov;121(2):419–424. doi: 10.1002/jcp.1041210221. [DOI] [PubMed] [Google Scholar]
  48. Rosenfeld R. G., Hintz R. L. Characterization of a specific receptor for somatomedin C (SM-C) on cultured human lymphocytes: evidence that SM-C modulates homologous receptor concentration. Endocrinology. 1980 Dec;107(6):1841–1848. doi: 10.1210/endo-107-6-1841. [DOI] [PubMed] [Google Scholar]
  49. Russell R. J., Wilkinson P. C., Sless F., Parrott D. M. Chemotaxis of lymphoblasts. Nature. 1975 Aug 21;256(5519):646–648. doi: 10.1038/256646a0. [DOI] [PubMed] [Google Scholar]
  50. Sara V. R., Hall K., Misaki M., Fryklund L., Christensen N., Wetterberg L. Ontogenesis of somatomedin and insulin receptors in the human fetus. J Clin Invest. 1983 May;71(5):1084–1094. doi: 10.1172/JCI110858. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Schimpff R. M., Repellin A. M., Salvatoni A., Thieriot-Prevost G., Chatelain P. Effect of purified somatomedins on thymidine incorporation into lectin-activated human lymphocytes. Acta Endocrinol (Copenh) 1983 Jan;102(1):21–26. doi: 10.1530/acta.0.1020021. [DOI] [PubMed] [Google Scholar]
  52. Snyderman R., Goetzl E. J. Molecular and cellular mechanisms of leukocyte chemotaxis. Science. 1981 Aug 21;213(4510):830–837. doi: 10.1126/science.6266014. [DOI] [PubMed] [Google Scholar]
  53. Snyderman R., Smith C. D., Verghese M. W. Model for leukocyte regulation by chemoattractant receptors: roles of a guanine nucleotide regulatory protein and polyphosphoinositide metabolism. J Leukoc Biol. 1986 Dec;40(6):785–800. doi: 10.1002/jlb.40.6.785. [DOI] [PubMed] [Google Scholar]
  54. Taylor S. I. Binding of hormones to receptors. An alternative explanation of nonlinear Scatchard plots. Biochemistry. 1975 Jun 3;14(11):2357–2361. doi: 10.1021/bi00682a013. [DOI] [PubMed] [Google Scholar]
  55. Thorsson A. V., Hintz R. L. Specific 125I-somatomedin receptor on circulating human mononuclear cells. Biochem Biophys Res Commun. 1977 Feb 21;74(4):1566–1573. doi: 10.1016/0006-291x(77)90621-0. [DOI] [PubMed] [Google Scholar]
  56. Underwood L. E., Clemmons D. R., Maes M., D'Ercole A. J., Ketelslegers J. M. Regulation of somatomedin-C/insulin-like growth factor I by nutrients. Horm Res. 1986;24(2-3):166–176. doi: 10.1159/000180556. [DOI] [PubMed] [Google Scholar]
  57. Underwood L. E., D'Ercole A. J. Insulin and insulin-like growth factors/somatomedins in fetal and neonatal development. Clin Endocrinol Metab. 1984 Mar;13(1):69–89. doi: 10.1016/s0300-595x(84)80009-2. [DOI] [PubMed] [Google Scholar]
  58. Williams L. T., Antoniades H. N., Goetzl E. J. Platelet-derived growth factor stimulates mouse 3T3 cell mitogenesis and leukocyte chemotaxis through different structural determinants. J Clin Invest. 1983 Nov;72(5):1759–1763. doi: 10.1172/JCI111135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Zapf J., Rinderknecht E., Humbel R. E., Froesch E. R. Nonsuppressible insulin-like activity (NSILA) from human serum: recent accomplishments and their physiologic implications. Metabolism. 1978 Dec;27(12):1803–1828. doi: 10.1016/0026-0495(78)90267-6. [DOI] [PubMed] [Google Scholar]
  60. Zapf J., Schmid C., Froesch E. R. Biological and immunological properties of insulin-like growth factors (IGF) I and II. Clin Endocrinol Metab. 1984 Mar;13(1):3–30. doi: 10.1016/s0300-595x(84)80006-7. [DOI] [PubMed] [Google Scholar]
  61. Zigmond S. H., Hirsch J. G. Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J Exp Med. 1973 Feb 1;137(2):387–410. doi: 10.1084/jem.137.2.387. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES